{"docId":"WPB_ENG_20101116.0049","headline":"Cancer Drug Faces Fed&apos;l Review (Washn)","named_entity":{"WASHINGTON":[[2,"LOCATION",1,1]],"Deutsche Bank":[[3,"ORGANIZATION",37,38]],"Medicare-eligible":[[13,"MISC",5,5]],"U.S.":[[7,"LOCATION",13,13]],"Bloomberg":[[4,"ORGANIZATION",29,29],[8,"ORGANIZATION",16,16]],"Food and Drug Administration":[[11,"ORGANIZATION",2,5]],"New York":[[3,"LOCATION",40,41]],"Karnauskas":[[9,"PERSON",14,14]],"Dendreon Corp.":[[2,"ORGANIZATION",3,4]],"Medicare":[[2,"ORGANIZATION",11,11],[6,"ORGANIZATION",11,11]],"Provenge":[[2,"MISC",25,25],[3,"MISC",16,16],[11,"MISC",7,7]],"Cancer Drug Faces Fed":[[1,"ORGANIZATION",1,4]],"Washn":[[1,"LOCATION",9,9]],"Robyn Karnauskas":[[3,"PERSON",34,35]],"Dendreon":[[15,"ORGANIZATION",16,16]],"Seattle-based":[[4,"MISC",15,15]]},"cluster_json":[[{"sent_ind":2,"word":"Dendreon Corp.","mention_type":"PROPER","token_ind":3,"end_ind":5},{"sent_ind":15,"word":"Dendreon 's","mention_type":"PROPER","token_ind":16,"end_ind":18}],[{"sent_ind":6,"word":"Medicare","mention_type":"PROPER","token_ind":11,"end_ind":12},{"sent_ind":2,"word":"Medicare","mention_type":"PROPER","token_ind":11,"end_ind":12}],[{"sent_ind":2,"word":"the company 's only product","mention_type":"NOMINAL","token_ind":27,"end_ind":32},{"sent_ind":3,"word":"Provenge","mention_type":"PROPER","token_ind":16,"end_ind":17},{"sent_ind":5,"word":"Provenge","mention_type":"PROPER","token_ind":1,"end_ind":2},{"sent_ind":4,"word":"Provenge","mention_type":"PROPER","token_ind":4,"end_ind":5},{"sent_ind":2,"word":"Provenge","mention_type":"PROPER","token_ind":25,"end_ind":26},{"sent_ind":14,"word":"Provenge","mention_type":"PROPER","token_ind":1,"end_ind":2},{"sent_ind":15,"word":"Provenge","mention_type":"PROPER","token_ind":32,"end_ind":33}],[{"sent_ind":12,"word":"this year","mention_type":"NOMINAL","token_ind":5,"end_ind":7},{"sent_ind":2,"word":"a year","mention_type":"NOMINAL","token_ind":18,"end_ind":20}],[{"sent_ind":3,"word":"the drug","mention_type":"NOMINAL","token_ind":30,"end_ind":32},{"sent_ind":2,"word":"the prostate cancer drug","mention_type":"NOMINAL","token_ind":21,"end_ind":25},{"sent_ind":12,"word":"the drug","mention_type":"NOMINAL","token_ind":29,"end_ind":31},{"sent_ind":6,"word":"the drug 's","mention_type":"NOMINAL","token_ind":21,"end_ind":24},{"sent_ind":7,"word":"the drug","mention_type":"NOMINAL","token_ind":7,"end_ind":9}],[{"sent_ind":7,"word":"the company","mention_type":"NOMINAL","token_ind":17,"end_ind":19},{"sent_ind":2,"word":"the company 's","mention_type":"NOMINAL","token_ind":27,"end_ind":30}],[{"sent_ind":3,"word":"New York","mention_type":"PROPER","token_ind":40,"end_ind":42}],[{"sent_ind":9,"word":"this panel","mention_type":"NOMINAL","token_ind":10,"end_ind":12},{"sent_ind":3,"word":"An advisory panel","mention_type":"NOMINAL","token_ind":1,"end_ind":4},{"sent_ind":11,"word":"an advisory panel","mention_type":"NOMINAL","token_ind":14,"end_ind":17}],[{"sent_ind":3,"word":"the agency to pay for the drug","mention_type":"NOMINAL","token_ind":25,"end_ind":32},{"sent_ind":12,"word":"The agency","mention_type":"NOMINAL","token_ind":1,"end_ind":3}],[{"sent_ind":4,"word":"Bloomberg","mention_type":"PROPER","token_ind":29,"end_ind":30},{"sent_ind":8,"word":"Bloomberg","mention_type":"PROPER","token_ind":16,"end_ind":17}],[{"sent_ind":4,"word":"2014 sales for the Seattle-based biotechnology company","mention_type":"NOMINAL","token_ind":11,"end_ind":18}],[{"sent_ind":6,"word":"The shares","mention_type":"NOMINAL","token_ind":1,"end_ind":3},{"sent_ind":8,"word":"shares","mention_type":"NOMINAL","token_ind":6,"end_ind":7}],[{"sent_ind":15,"word":"three","mention_type":"PROPER","token_ind":18,"end_ind":19},{"sent_ind":7,"word":"Three of four people","mention_type":"PROPER","token_ind":1,"end_ind":5}],[{"sent_ind":9,"word":"Karnauskas","mention_type":"PROPER","token_ind":14,"end_ind":15}],[{"sent_ind":10,"word":"It","mention_type":"PRONOMINAL","token_ind":2,"end_ind":3},{"sent_ind":9,"word":"a lot of fear","mention_type":"NOMINAL","token_ind":5,"end_ind":9},{"sent_ind":10,"word":"a stock people are afraid to own","mention_type":"NOMINAL","token_ind":4,"end_ind":11}],[{"sent_ind":9,"word":"a telephone interview","mention_type":"NOMINAL","token_ind":17,"end_ind":20}],[{"sent_ind":14,"word":"the study","mention_type":"NOMINAL","token_ind":11,"end_ind":13},{"sent_ind":12,"word":"a third study in 512 patients","mention_type":"NOMINAL","token_ind":15,"end_ind":21}],[{"sent_ind":15,"word":"this week 's meeting","mention_type":"NOMINAL","token_ind":8,"end_ind":12}],[],[],[],[],[],[],[],[],[],[],[],[]],"text":[["Cancer","Drug","Faces","Fed","'","l","Review","-LRB-","Washn","-RRB-","."],["WASHINGTON","-","Dendreon","Corp.","is","relying","on","a","decision","by","Medicare","to","help","generate","$","1.75","billion","a","year","for","the","prostate","cancer","drug","Provenge",",","the","company","'s","only","product","."],["An","advisory","panel","is","expected","to","vote","Wednesday","on","whether","there","is","adequate","evidence","that","Provenge","extends","life",",","a","ruling","that","may","lead","the","agency","to","pay","for","the","drug",",","said","Robyn","Karnauskas","of","Deutsche","Bank","in","New","York","."],["With","reimbursement",",","Provenge","would","generate","$","1.75","billion","in","2014","sales","for","the","Seattle-based","biotechnology","company",",","according","to","the","average","estimate","of","four","analysts","compiled","by","Bloomberg","."],["Provenge","was","cleared","for","sale","on","April","29","."],["The","shares","have","fallen","29","percent","since","then","on","concerns","Medicare","may","decide","not","to","pay","for","coverage","because","of","the","drug","'s","$","93,000","cost","and","inconsistency","in","study","results","."],["Three","of","four","people","recommended","for","the","drug","are","eligible","for","the","U.S.","health","plan",",","the","company","has","said","."],["An","affirmative","finding","may","boost","shares","60","percent",",","according","to","nine","analysts","surveyed","by","Bloomberg","."],["``","There","'s","been","a","lot","of","fear","around","this","panel",",","''","Karnauskas","said","in","a","telephone","interview","."],["``","It","'s","a","stock","people","are","afraid","to","own",".","''"],["The","Food","and","Drug","Administration","rejected","Provenge","in","2007","against","the","recommendation","of","an","advisory","panel","after","one","of","two","studies","failed","to","show","a","benefit","."],["The","agency","granted","approval","this","year","for","use","in","advanced","prostate","cancer","based","on","a","third","study","in","512","patients","with","a","median","survival","of","25.8","months","on","the","drug",",","compared","with","21.7","months","on","a","placebo","."],["The","survival","benefit","in","Medicare-eligible","patients","was","more","than","six","months","."],["Provenge","reduced","the","risk","of","death","by","22.5","percent","in","the","study","."],["An","independent","technology","assessment","released","ahead","of","this","week","'s","meeting","concluded","the","data","from","Dendreon","'s","three","trials","``","are","consistent","with","longer","overall","survival","''","in","patients","approved","for","Provenge","."]],"part_of_speech":[["NNP","NNP","VBZ","NNP","POS","NN","NN","-LRB-","NN","-RRB-","."],["NNP",":","NNP","NNP","VBZ","VBG","IN","DT","NN","IN","NNP","TO","VB","VB","$","CD","CD","DT","NN","IN","DT","NN","NN","NN","NNP",",","DT","NN","POS","JJ","NN","."],["DT","JJ","NN","VBZ","VBN","TO","VB","NNP","IN","IN","EX","VBZ","JJ","NN","IN","NNP","VBZ","NN",",","DT","NN","WDT","MD","VB","DT","NN","TO","VB","IN","DT","NN",",","VBD","NNP","NNP","IN","NNP","NNP","IN","NNP","NNP","."],["IN","NN",",","NNP","MD","VB","$","CD","CD","IN","CD","NNS","IN","DT","JJ","NN","NN",",","VBG","TO","DT","JJ","NN","IN","CD","NNS","VBN","IN","NNP","."],["NNP","VBD","VBN","IN","NN","IN","NNP","CD","."],["DT","NNS","VBP","VBN","CD","NN","IN","RB","IN","NNS","NNP","MD","VB","RB","TO","VB","IN","NN","IN","IN","DT","NN","POS","$","CD","NN","CC","NN","IN","NN","NNS","."],["CD","IN","CD","NNS","VBD","IN","DT","NN","VBP","JJ","IN","DT","NNP","NN","NN",",","DT","NN","VBZ","VBN","."],["DT","JJ","NN","MD","VB","NNS","CD","NN",",","VBG","TO","CD","NNS","VBN","IN","NNP","."],["``","EX","VBZ","VBN","DT","NN","IN","NN","IN","DT","NN",",","''","NNPS","VBD","IN","DT","NN","NN","."],["``","PRP","VBZ","DT","NN","NNS","VBP","JJ","TO","VB",".","''"],["DT","NNP","CC","NNP","NNP","VBD","NNP","IN","CD","IN","DT","NN","IN","DT","JJ","NN","IN","CD","IN","CD","NNS","VBD","TO","VB","DT","NN","."],["DT","NN","VBN","NN","DT","NN","IN","NN","IN","JJ","NN","NN","VBN","IN","DT","JJ","NN","IN","CD","NNS","IN","DT","JJ","NN","IN","CD","NNS","IN","DT","NN",",","VBN","IN","CD","NNS","IN","DT","NN","."],["DT","NN","NN","IN","JJ","NNS","VBD","RBR","IN","CD","NNS","."],["NNP","VBD","DT","NN","IN","NN","IN","CD","NN","IN","DT","NN","."],["DT","JJ","NN","NN","VBN","RB","IN","DT","NN","POS","NN","VBD","DT","NNS","IN","NNP","POS","CD","NNS","``","VBP","JJ","IN","JJR","JJ","NN","''","IN","NNS","VBN","IN","NNP","."]],"totalParse":{"1":[[0,3,"root"],[2,1,"compound"],[3,2,"nsubj"],[3,7,"dobj"],[3,11,"punct"],[4,5,"case"],[7,4,"nmod:poss"],[7,6,"compound"],[7,9,"appos"],[9,8,"punct"],[9,10,"punct"]],"2":[[0,31,"root"],[4,3,"compound"],[4,1,"compound"],[4,2,"punct"],[6,4,"nsubj"],[6,5,"aux"],[6,9,"nmod$on"],[9,7,"case"],[9,8,"det"],[9,11,"nmod$by"],[9,13,"acl"],[11,10,"case"],[13,12,"mark"],[13,14,"ccomp"],[14,25,"nmod$for"],[14,15,"dobj"],[15,19,"nmod:npmod"],[15,17,"nummod"],[17,16,"compound"],[19,18,"det"],[25,20,"case"],[25,21,"det"],[25,22,"compound"],[25,23,"compound"],[25,24,"compound"],[28,27,"det"],[28,29,"case"],[31,6,"ccomp"],[31,26,"punct"],[31,28,"nmod:poss"],[31,30,"amod"],[31,32,"punct"]],"3":[[0,33,"root"],[7,6,"mark"],[7,8,"nmod:tmod"],[7,12,"advcl"],[7,3,"nsubj"],[12,9,"mark"],[12,10,"mark"],[12,11,"expl"],[12,14,"nsubj"],[14,13,"amod"],[14,17,"ccomp"],[17,15,"mark"],[17,16,"nsubj"],[17,18,"dobj"],[18,19,"punct"],[18,21,"appos"],[21,22,"ref"],[21,24,"acl:relcl"],[21,20,"det"],[24,23,"aux"],[24,26,"dobj"],[24,28,"xcomp"],[24,21,"nsubj"],[26,25,"det"],[28,26,"nsubj"],[28,27,"mark"],[28,31,"nmod$for"],[31,29,"case"],[31,30,"det"],[33,42,"punct"],[33,32,"punct"],[33,35,"nsubj"],[33,5,"ccomp"],[35,38,"nmod$of"],[35,34,"compound"],[38,41,"nmod$in"],[38,36,"case"],[38,37,"compound"],[41,39,"case"],[41,40,"compound"],[3,1,"det"],[3,2,"amod"],[5,7,"xcomp"],[5,3,"nsubjpass"],[5,4,"auxpass"]],"4":[[0,6,"root"],[2,1,"case"],[6,30,"punct"],[6,2,"nmod$with"],[6,18,"punct"],[6,3,"punct"],[6,4,"nsubj"],[6,5,"aux"],[6,7,"dobj"],[6,23,"nmod$according_to"],[7,9,"nummod"],[7,12,"nmod$in"],[9,8,"compound"],[12,10,"case"],[12,11,"nummod"],[12,17,"nmod$for"],[17,13,"case"],[17,14,"det"],[17,15,"amod"],[17,16,"compound"],[19,20,"mwe"],[23,26,"nmod$of"],[23,19,"case"],[23,21,"det"],[23,22,"amod"],[26,25,"nummod"],[26,27,"acl"],[26,24,"case"],[27,29,"nmod$by"],[29,28,"case"]],"5":[[0,3,"root"],[3,1,"nsubjpass"],[3,2,"auxpass"],[3,5,"nmod$for"],[3,9,"punct"],[5,4,"case"],[5,7,"nmod$on"],[7,6,"case"],[7,8,"nummod"]],"6":[[0,4,"root"],[2,1,"det"],[4,32,"punct"],[4,2,"nsubj"],[4,3,"aux"],[4,6,"dobj"],[4,8,"nmod$since"],[6,5,"nummod"],[8,7,"case"],[8,10,"nmod$on"],[10,9,"case"],[10,13,"acl:relcl"],[13,16,"xcomp"],[13,11,"nsubj"],[13,12,"aux"],[16,15,"mark"],[16,18,"nmod$for"],[16,22,"nmod$because_of"],[16,11,"nsubj"],[16,14,"neg"],[18,17,"case"],[19,20,"mwe"],[22,19,"case"],[22,21,"det"],[22,23,"case"],[22,26,"acl:relcl"],[22,28,"acl:relcl"],[24,25,"nummod"],[26,31,"nmod$in"],[26,24,"nsubj"],[26,27,"cc"],[26,28,"conj$and"],[31,29,"case"],[31,30,"compound"]],"7":[[0,20,"root"],[18,17,"det"],[20,18,"nsubj"],[20,19,"aux"],[20,5,"ccomp"],[20,21,"punct"],[20,16,"punct"],[3,2,"advmod"],[3,1,"compound"],[4,3,"nummod"],[5,4,"nsubj"],[5,8,"nmod$for"],[5,10,"ccomp"],[8,6,"case"],[8,7,"det"],[10,9,"cop"],[10,15,"nmod$for"],[15,11,"case"],[15,12,"det"],[15,13,"compound"],[15,14,"compound"]],"8":[[0,5,"root"],[3,1,"det"],[3,2,"amod"],[5,8,"dobj"],[5,9,"punct"],[5,13,"nmod$according_to"],[5,17,"punct"],[5,3,"nsubj"],[5,4,"aux"],[8,6,"compound"],[8,7,"nummod"],[10,11,"mwe"],[13,10,"case"],[13,12,"nummod"],[13,14,"acl"],[14,16,"nmod$by"],[16,15,"case"]],"9":[[0,15,"root"],[6,8,"nmod$of"],[6,2,"expl"],[6,3,"auxpass"],[6,4,"cop"],[6,5,"det"],[8,11,"nmod$around"],[8,7,"case"],[11,9,"case"],[11,10,"det"],[15,12,"punct"],[15,13,"punct"],[15,14,"nsubj"],[15,1,"punct"],[15,19,"nmod$in"],[15,20,"punct"],[15,6,"ccomp"],[19,16,"case"],[19,17,"det"],[19,18,"compound"]],"10":[[0,6,"root"],[6,11,"punct"],[6,12,"punct"],[6,1,"punct"],[6,2,"nsubj"],[6,3,"cop"],[6,4,"det"],[6,5,"compound"],[6,8,"amod"],[8,7,"cop"],[8,10,"xcomp"],[10,9,"mark"]],"11":[[0,6,"root"],[2,3,"cc"],[2,4,"conj$and"],[5,1,"det"],[5,2,"compound"],[5,4,"compound"],[6,18,"nmod$after"],[6,5,"nsubj"],[6,7,"dobj"],[6,27,"punct"],[7,9,"nmod$in"],[7,12,"nmod$against"],[9,8,"case"],[12,16,"nmod$of"],[12,10,"case"],[12,11,"det"],[16,14,"det"],[16,15,"amod"],[16,13,"case"],[18,17,"case"],[18,21,"nmod$of"],[18,22,"acl"],[21,19,"case"],[21,20,"nummod"],[22,24,"xcomp"],[24,23,"mark"],[24,26,"dobj"],[26,25,"det"]],"12":[[0,4,"root"],[2,1,"det"],[4,2,"nsubj"],[4,3,"amod"],[4,35,"advcl$compared_with"],[4,6,"nmod:tmod"],[4,39,"punct"],[4,8,"nmod$for"],[4,31,"punct"],[6,5,"det"],[8,17,"acl$based_on"],[8,7,"case"],[8,12,"nmod$in"],[12,9,"case"],[12,10,"amod"],[12,11,"compound"],[13,14,"mwe"],[17,20,"nmod$in"],[17,13,"case"],[17,15,"det"],[17,16,"amod"],[20,18,"case"],[20,19,"nummod"],[20,24,"nmod$with"],[24,21,"case"],[24,22,"det"],[24,23,"amod"],[24,27,"nmod$of"],[24,30,"nmod$on"],[27,25,"case"],[27,26,"nummod"],[30,28,"case"],[30,29,"det"],[32,33,"mwe"],[35,34,"nummod"],[35,38,"nmod$on"],[35,32,"case"],[38,36,"case"],[38,37,"det"]],"13":[[0,11,"root"],[6,4,"case"],[6,5,"amod"],[8,9,"mwe"],[10,8,"advmod"],[11,7,"cop"],[11,10,"nummod"],[11,12,"punct"],[11,3,"nsubj"],[3,6,"nmod$in"],[3,1,"det"],[3,2,"compound"]],"14":[[0,2,"root"],[9,7,"case"],[9,8,"nummod"],[9,12,"nmod$in"],[12,10,"case"],[12,11,"det"],[2,9,"nmod$by"],[2,13,"punct"],[2,1,"nsubj"],[2,4,"dobj"],[4,3,"det"],[4,6,"nmod$of"],[6,5,"case"]],"15":[[0,12,"root"],[4,1,"det"],[4,2,"amod"],[4,3,"compound"],[4,5,"acl"],[5,6,"advmod"],[6,11,"nmod$of"],[9,10,"case"],[9,8,"det"],[11,7,"case"],[11,9,"nmod:poss"],[12,33,"punct"],[12,4,"nsubj"],[12,22,"ccomp"],[14,13,"det"],[14,19,"nmod$from"],[16,17,"case"],[19,15,"case"],[19,16,"nmod:poss"],[19,18,"nummod"],[22,26,"nmod$with"],[22,14,"nsubj"],[22,20,"punct"],[22,21,"cop"],[26,27,"punct"],[26,29,"nmod$in"],[26,23,"case"],[26,24,"amod"],[26,25,"amod"],[29,28,"case"],[29,30,"acl"],[30,32,"nmod$for"],[32,31,"case"]]},"processed":{"1":[{"edgeName":"nsubj","govWord":"Faces Review .","depWord":"Cancer Drug","dep":[1,2],"gov":[3,7,11]},{"edgeName":"dobj","govWord":"Drug Faces .","depWord":"Fed l Review Washn","dep":[4,6,7,9],"gov":[2,3,11]},{"edgeName":"appos","govWord":"Fed l Review","depWord":"-LRB- Washn -RRB-","dep":[8,9,10],"gov":[4,6,7]}],"2":[{"edgeName":"nsubj","govWord":"is relying decision","depWord":"WASHINGTON - Dendreon Corp.","dep":[1,2,3,4],"gov":[5,6,9]},{"edgeName":"dobj","govWord":"generate Provenge","depWord":"$ billion year","dep":[15,17,19],"gov":[14,25]}],"3":[{"edgeName":"nsubj","govWord":"to vote Wednesday is","depWord":"An advisory panel","dep":[1,2,3],"gov":[6,7,8,12]},{"edgeName":"nsubj","govWord":"on whether there is","depWord":"adequate evidence extends","dep":[13,14,17],"gov":[9,10,11,12]},{"edgeName":"nsubj","govWord":"that extends life","depWord":"Provenge","dep":[16],"gov":[15,17,18]},{"edgeName":"dobj","govWord":"that Provenge extends","depWord":"life , ruling","dep":[18,19,21],"gov":[15,16,17]},{"edgeName":"appos","govWord":"life ,","depWord":"a ruling that lead","dep":[20,21,22,24],"gov":[18,19]},{"edgeName":"dobj","govWord":"ruling may lead pay","depWord":"the agency","dep":[25,26],"gov":[21,23,24,28]},{"edgeName":"nsubj","govWord":"may lead agency pay","depWord":"a ruling that","dep":[20,21,22],"gov":[23,24,26,28]},{"edgeName":"nsubj","govWord":"to pay drug","depWord":"the agency","dep":[25,26],"gov":[27,28,31]},{"edgeName":"nsubj","govWord":"expected , said .","depWord":"Robyn Karnauskas Bank","dep":[34,35,38],"gov":[5,32,33,42]},{"edgeName":"nsubjpass","govWord":"is expected vote","depWord":"An advisory panel","dep":[1,2,3],"gov":[4,5,7]}],"4":[{"edgeName":"nsubj","govWord":"reimbursement , would generate $ , estimate .","depWord":"Provenge","dep":[4],"gov":[2,3,5,6,7,18,23,30]},{"edgeName":"dobj","govWord":"reimbursement , Provenge would generate , estimate .","depWord":"$ billion sales","dep":[7,9,12],"gov":[2,3,4,5,6,18,23,30]}],"5":[{"edgeName":"nsubjpass","govWord":"was cleared sale .","depWord":"Provenge","dep":[1],"gov":[2,3,5,9]}],"6":[{"edgeName":"nsubj","govWord":"have fallen percent then .","depWord":"The shares","dep":[1,2],"gov":[3,4,6,8,32]},{"edgeName":"dobj","govWord":"shares have fallen then .","depWord":"29 percent","dep":[5,6],"gov":[2,3,4,8,32]},{"edgeName":"nsubj","govWord":"may decide pay","depWord":"Medicare","dep":[11],"gov":[12,13,16]},{"edgeName":"nsubj","govWord":"not to pay coverage drug","depWord":"Medicare","dep":[11],"gov":[14,15,16,18,22]},{"edgeName":"nsubj","govWord":"cost and inconsistency results","depWord":"$ 93,000","dep":[24,25],"gov":[26,27,28,31]}],"7":[{"edgeName":"nsubj","govWord":"recommended , has said .","depWord":"the company","dep":[17,18],"gov":[5,16,19,20,21]},{"edgeName":"nsubj","govWord":"recommended drug eligible","depWord":"four people","dep":[3,4],"gov":[5,8,10]}],"8":[{"edgeName":"dobj","govWord":"finding may boost , analysts .","depWord":"shares 60 percent","dep":[6,7,8],"gov":[3,4,5,9,13,17]},{"edgeName":"nsubj","govWord":"may boost percent , analysts .","depWord":"An affirmative finding","dep":[1,2,3],"gov":[4,5,8,9,13,17]}],"9":[{"edgeName":"nsubj","govWord":"`` lot , '' said interview .","depWord":"Karnauskas","dep":[14],"gov":[1,6,12,13,15,19,20]}],"10":[{"edgeName":"nsubj","govWord":"`` 's a stock people afraid . ''","depWord":"It","dep":[2],"gov":[1,3,4,5,6,8,11,12]}],"11":[{"edgeName":"nsubj","govWord":"rejected Provenge one .","depWord":"The Food Drug Administration","dep":[1,2,4,5],"gov":[6,7,18,27]},{"edgeName":"dobj","govWord":"Administration rejected one .","depWord":"Provenge 2007 recommendation","dep":[7,9,12],"gov":[5,6,18,27]},{"edgeName":"dobj","govWord":"to show","depWord":"a benefit","dep":[25,26],"gov":[23,24]}],"12":[{"edgeName":"nsubj","govWord":"granted approval year use , months .","depWord":"The agency","dep":[1,2],"gov":[3,4,6,8,31,35,39]}],"13":[{"edgeName":"nsubj","govWord":"was six months .","depWord":"The survival benefit patients","dep":[1,2,3,6],"gov":[7,10,11,12]}],"14":[{"edgeName":"nsubj","govWord":"reduced risk percent .","depWord":"Provenge","dep":[1],"gov":[2,4,9,13]},{"edgeName":"dobj","govWord":"Provenge reduced percent .","depWord":"the risk death","dep":[3,4,6],"gov":[1,2,9,13]}],"15":[{"edgeName":"nsubj","govWord":"concluded consistent .","depWord":"An independent technology assessment released","dep":[1,2,3,4,5],"gov":[12,22,33]},{"edgeName":"nsubj","govWord":"`` are consistent survival","depWord":"the data trials","dep":[13,14,19],"gov":[20,21,22,26]}]}}